3 Stocks Insiders Are Buying Non-Stop
Insider buying is one of the few market signals that does not hide behind algorithms or price targets. When a director pulls out a personal checkbook and adds to his stake while…
Insider buying is one of the few market signals that does not hide behind algorithms or price targets. When a director pulls out a personal checkbook and adds to his stake while…
Healthcare investing has felt like walking through quicksand this year. One moment, the sector looks ready to spring forward on breakthrough drugs and aging demographics, the next, it is yanked back by…
A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway success of Novo Nordisk’s (NYSE:NVO | NVO Price Prediction) Ozempic and Wegovy. These injectable…
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) has been a trailblazer in the GLP-1 drug market, revolutionizing diabetes and obesity treatment with its blockbuster…
Live Updates Tuesday Wrap-up4:12pm ETThe Vanguard S&P 500 ETF closed at 588.15 Tuesday, down 0.5%. Softbank Rides to Intel's Rescue12:10pm ET“Great minds think alike,” goes the old saying, and today, one of…
Live Updates Monday Wrap-up4:11pm ETThe Vanguard S&P 500 ETF closed at 591.36 Monday, down 0.04%. BREAKING NEWS: INTEL12:32pm ETBloomberg just reported — literal seconds ago — that the Trump Administration is discussing…
Weighing the Options The introduction of Novo Nordisk’s (NYSE:NVO | NVO Price Prediction) Ozempic revolutionized the fight against obesity, shifting the narrative from lifestyle interventions to pharmacological solutions. Glucagon-like peptide-1 (GLP-1) receptor…
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) is watching its stock plummet 20% in morning trading after slashing its full-year sales and profit outlook for the second time this…
Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by…
Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it allows investors to buy high-quality companies at bargain prices. When market sentiment…
If you wish to turn $10,000 into $50,000 by 2035, you’re looking at a 400% gain over a 10-year horizon. In the past decade, the S&P 500 has gained 194%, and the…
With over $5 trillion of new investment commitments to date, the U.S. is experiencing a business renaissance being incentivized by President Trump. So far, $1.4 trillion has been committed by U.A.E., $600…
Jim Cramer has a mixed record when it comes to choosing stocks. Therefore, he also has a mixed reputation in the investing space. But that doesn’t diminish his influence as an average…
Live Updates Thursday Wrap-Up4:32pm ETThe Vanguard S&P 500 ETF closed Thursday at 564.20, up 0.8%. Game On for Meta1:33pm ETBloomberg is reporting that Meta Platforms (Nasdaq: META | META Price Prediction) is…
The Power of Long-Term Investing Long-term investing is the cornerstone of wealth creation, prioritizing steady growth over fleeting market spikes. Before buying stocks, investors should go into it with the idea of…